Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:42 pm Purchase |
2024-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 10,875,454 9.900% |
1,779,865 (+19.57%) |
Filing History |
| 2025-02-14 4:50 pm Sale |
2024-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 6,978,534 6.500% |
-1,046,031 (-13.04%) |
Filing History |
| 2024-12-17 5:35 pm Purchase |
2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
BCLS II Investco LP | 10,719,110 13.000% |
5,342,754 (+99.38%) |
Filing History |
| 2024-12-17 4:00 pm Sale |
2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Forbion Capital Fund IV Cooperatief U.A. | 11,123,614 10.400% |
-696,949 (-5.90%) |
Filing History |
| 2024-12-17 10:28 am Purchase |
2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 16,416,751 15.300% |
3,784,713 (+29.96%) |
Filing History |
| 2024-11-15 4:29 pm Sale |
2024-11-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Forbion Capital Fund IV Cooperatief U.A. | 11,820,563 12.800% |
-10,898 (-0.09%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 9,095,589 9.990% |
898,256 (+10.96%) |
Filing History |
| 2024-08-23 4:20 pm Sale |
2024-08-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
AMGEN INC AMGN |
0 0.000% |
-4,910,000 (Position Closed) |
Filing History |
| 2024-03-01 4:30 pm Unchanged |
2024-02-28 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
BCLS II Investco LP | 5,376,356 6.000% |
0 (Unchanged) |
Filing History |
| 2024-02-21 11:11 am Unchanged |
2024-02-16 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 12,632,038 14.200% |
0 (Unchanged) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2024-02-14 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 8,197,333 9.900% |
-1,136,000 (-12.17%) |
Filing History |
| 2024-02-14 10:12 am Purchase |
2023-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 8,024,565 9.700% |
1,500,000 (+22.99%) |
Filing History |
| 2023-09-19 9:30 pm Purchase |
2023-09-11 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
Morningside Venture Investments Limited | 4,060,923 4.930% |
4,060,923 (New Position) |
Filing History |
| 2023-08-15 4:02 pm Purchase |
2023-08-11 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 12,632,038 15.300% |
1,485,807 (+13.33%) |
Filing History |
| 2023-08-01 4:30 pm Purchase |
2023-06-08 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 9,333,333 11.300% |
5,000,000 (+115.38%) |
Filing History |
| 2023-07-07 5:06 pm Purchase |
2023-06-05 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Forbion Capital Fund IV Cooperatief U.A. | 11,831,461 14.500% |
3,589,061 (+43.54%) |
Filing History |
| 2023-07-07 5:00 pm Purchase |
2022-11-22 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Forbion Capital Fund IV Cooperatief U.A. | 8,242,400 10.100% |
8,242,400 (New Position) |
Filing History |
| 2023-06-20 4:30 pm Purchase |
2023-06-07 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% |
6,524,565 (New Position) |
Filing History |
| 2023-06-13 5:04 pm Purchase |
2023-06-09 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
BCLS II Investco LP | 5,376,356 6.600% |
1,376,356 (+34.41%) |
Filing History |
| 2023-06-09 3:47 pm Purchase |
2023-06-07 | 13D | NewAmsterdam Pharma Company N.V. NAMS |
Frazier Life Sciences X L.P. | 11,146,231 13.500% |
11,146,231 (New Position) |
Filing History |